Maria Elia Sadek

Association between fibroblast growth factor 23 and left ventricular hypertrophy in Egyptian patients on regular hemodialysis

Abstract Background Cardiovascular disease remains the leading cause of mortality in end-stage renal disease (ESRD) patients, with left ventricular hypertrophy (LVH) representing a prevalent and prognostically significant complication. Fibroblast growth factor 23 (FGF23), a bone-...